( 42 ) reported no statistically significant difference in PR with SBRT dose (<14 Gy vs ≥14 Gy) in a mixed diagnosis population, although a strong trend toward increased PR was reported with dose no less than 14 Gy.
← all excerpts
Systematic Review of the Role of Stereotactic Radiotherapy for Bone Metastases.
1
—
—